South West Regional Experience of Alpelisib and Fulvestrant in Patients with a PIK3CA Mutation

被引：0
|
作者：
Crocker, C. [1 ]
Mckeon, J. [2 ]
Dacie, R. [3 ]
Amaya, M. [4 ]
机构：
[1] Royal United Hosp Bath NHS Fdn Trust, Bath, Avon, England
[2] Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol, Avon, England
[3] Gloucestershire Hosp NHS Fdn Trust, Gloucester, England
[4] Somerset NHS Fdn Trust, Yeovil, England
来源：
CLINICAL ONCOLOGY | 2024年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E108 / E109
页数：2
相关论文
共 50 条
  • [1] Alpelisib plus fulvestrant for PIK3CA-mutated breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (07): : E347 - E347
  • [2] Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation
    de Godoy, Bianca Lara Venancio
    Moschetta-Pinheiro, Marina Gobbe
    Chuffa, Luiz Gustavo de Almeida
    Ponde, Noam Falbel
    Reiter, Russel J.
    Colombo, Jucimara
    Zuccari, Debora Aparecida Pires de Campos
    LIFE SCIENCES, 2023, 324
  • [3] PIK3CA Mutation Detection by Pyrosequencing
    Baker, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 902 - 902
  • [4] Rare mutation of PIK3CA in meningiomas
    Jesse Chung-sean Pang
    Nellie Yuk Fei Chung
    Norman Hok Ling Chan
    Wai Sang Poon
    Teresa Thomas
    Ho-keung Ng
    Acta Neuropathologica, 2006, 111 : 284 - 285
  • [5] Rare mutation of PIK3CA in meningiomas
    Pang, JCS
    Chung, NYF
    Chan, NHL
    Poon, WS
    Thomas, T
    Ng, HK
    ACTA NEUROPATHOLOGICA, 2006, 111 (03) : 284 - 285
  • [6] Treatment of a Patient with PIK3CA mutant metastatic Porocarcinoma with Alpelisib and Radiotherapy
    Horbruegger, M.
    Lenz, F. S.
    Franke, I.
    Tueting, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 6 - 6
  • [7] PIK3CA mutation profiling in Vietnamese patients with breast cancer
    Vuong, Linh Dieu
    Ta, To Van
    Chu, Ha Hoang
    Truong, Van-Long
    Nguyen, Quang Ngoc
    META GENE, 2020, 25
  • [8] PIK3CA mutation status in Japanese lung cancer patients
    Kawano, Osamu
    Sasaki, Hidefumi
    Endo, Katsuhiko
    Suzuki, Eriko
    Haneda, Hiroshi
    Yukiue, Haruhiro
    Kobayashi, Yoshihiro
    Yano, Motoki
    Fujii, Yoshitaka
    LUNG CANCER, 2006, 54 (02) : 209 - 215
  • [9] Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations
    Hyman, David M.
    Tran, Ben
    Paz-Ares, Luis
    Machiels, Jean-Pascal
    Schellens, Jan H.
    Bedard, Philippe L.
    Campone, Mario
    Cassier, Philippe A.
    Sarantopoulos, John
    Vaishampayan, Ulka
    Chugh, Rashmi
    Mahipal, Amit
    Lockhart, A. Craig
    Sessa, Cristiana
    Zander, Thomas
    Ng, Matthew
    Curigliano, Giuseppe
    Bendiske, Jennifer
    Chen, Xueying
    Choudhury, Somesh
    Graus-Porta, Diana
    Lewis, Nancy
    Perez Garcia, Jose Manuel
    Jose de Miguel-Luken, Maria
    JCO PRECISION ONCOLOGY, 2019, 3
  • [10] A PIK3CA mutation in an acquired capillary malformation
    Rosenthal, Jaclyn
    Sibbald, Cathryn
    Jen, Melinda
    Deardorff, Matthew A.
    Treat, James
    PEDIATRIC DERMATOLOGY, 2020, 37 (01) : 246 - 247
12345